Celia Sepulveda joined Micronoma formally in April of 2022 as the Corporate Communications Director, though she has been working with Micronoma as a consultant from the announced launch in fall of 2020. Born in Santa Rosa, California and raised in New Jersey, she has...
Andrew Lin joined Micronoma in July 2021 as a CLS Supervisor and is responsible for building, operating, and managing a clinical lab that is compliant with all CLIA/CAP/NY regulations. Though originally from Yorba Linda, Ca, he has lived in San Diego for the last four...
As we pave the way for better patient outcomes with the first minimally invasive microbiome-driven liquid biopsy technology, we also want to make sure that the important economic benefits that health insurance companies will reap from covering early cancer screening...
Stephen Wandro joined Micronoma in August 2020 as a senior scientist, with a speciality in analyzing DNA sequencing data. He is responsible for building computational pipelines and interpreting biological data with statistics and machine learning. He organizes and...
It’s no exaggeration to say the development of Micronoma’s Oncobiota™ microbiome-driven liquid-biopsy technology to detect cancer at an early stage would not be possible without extensive expertise and use of machine learning (ML) tools. Micronoma’s proprietary...
Chuck Rosales joined Micronoma in July 2021 as the quality manager, responsible for implementing and maintaining all compliance and quality procedures to ensure that patient testing is performed with the highest standards. Though born in Kansas, he has lived in San...
